Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer

  • Deepak Poduval,
  • Zuzana Sichmanova,
  • Anne Hege Straume,
  • Per Eystein Lønning,
  • Stian Knappskog

Fig 1 is missing part B. The authors have provided a corrected version here.

Fig 8 is missing part B. The authors have provided a corrected version here.

thumbnail
Fig 1. Predicted novel miRNAs.

Depiction of novel miRNAs (A) hsa-miR-nov3 and (B) hsa-miR-nov7, identified by miRDeep2, showing (i) predicted mature and star sequences, exp, probabilistic model expected from Drosha/Dicer processing and obs, observed sequences from sequencing data (ii) density plot for read counts for mature and star sequences as well as (iii) miRNA secondary structure.

https://doi.org/10.1371/journal.pone.0253361.g001

thumbnail
Fig 8. miRNAs and breast cancer survival.

Kaplan-Meier curves showing (i) disease-specific and (ii) relapse-free survival of locally advanced breast cancer patients treated with epirubicin or paclitaxel monotherapy in the neoadjuvant setting (study 1), with respect to expression levels of (A) hsa-miR-nov3 and (B) hsa-miR-nov7 on all samples.

https://doi.org/10.1371/journal.pone.0253361.g002

Reference

  1. 1. Poduval D, Sichmanova Z, Straume AH, Lønning PE, Knappskog S (2020) The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer. PLoS ONE 15(4): e0225357. https://doi.org/10.1371/journal.pone.0225357 pmid:32298266